ArticleFrontiers in cardiovascular medicine2025
Synthetic fibrosis distributions for data augmentation in predicting atrial fibrillation ablation outcomes: an
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Atrial fibrosis in atrial fibrillation: Mechanisms, mapping techniques and clinical applications.The Journal of physiology · 2026Review
- Towards mechanisms-driven strategy for persistent atrial fibrillation ablation: Leveraging digital twins.Journal of precision medicine (Amsterdam, Netherlands) · 2026Article
- Virtual population-based analysis of anatomical and electrophysiological risk markers for atrial fibrillation.JRSM cardiovascular diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cardiac fibrosis influences atrial fibrillation (AF) progression and ablation outcomes, with late gadolinium enhancement (LGE) MRI providing a non-invasive tool to measure fibrosis distributions. While deep learning (DL) has shown promise in predicting ablation success, training such pipelines is limited by the availability of real patient data. Methods: In this study, we generated synthetic fibrosis distributions using a denoising diffusion probabilistic model trained on a collection of 100 real LGE-MRI distributions. We incorporated them into 1,000 bi-atrial meshes derived from a statistical shape model and simulated AF episodes on them before and after various ablation strategies to expand the training dataset for DL-based outcome prediction. Our approach aims to improve the predictive performance of the DL pipeline by enhancing dataset diversity and better-capturing patient variability. Results: We showed that the fibrosis distributions generated by the diffusion model closely resemble real LGE-MRI distributions, based on metrics such as mean intensities ( Conclusion: We have shown the ability of synthetic fibrosis distributions to be a data augmentation tool for deep learning classification of outcomes of various ablation strategies, which may enable rapid and precise assessment of atrial fibrillation treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.